Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Glück

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Clinical Breast Cancer|December 21, 2013
Extending the clinical benefit of endocrine therapy for women with hormone receptor-positive metastatic breast cancer: differentiating mechanisms of actionStefan Glück
The Oncologist|November 30, 2005
Adjuvant chemotherapy for early breast cancer: optimal use of epirubicinStefan Glück
Cancer Investigation|March 17, 2007
The prevention and management of distant metastases in women with breast cancerStefan Glück
American Journal of Clinical Oncology|September 5, 2009
Exemestane as first-line therapy in postmenopausal women with recurrent or metastatic breast cancerStefan Glück
Clinical Breast Cancer|October 1, 2016
Consequences of the Convergence of Multiple Alternate Pathways on the Estrogen Receptor in the Treatment of Metastatic Breast CancerStefan Glück
Clinical Breast Cancer|May 9, 2014
nab-Paclitaxel for the treatment of aggressive metastatic breast cancerStefan Glück
Cancer Control : Journal of the Moffitt Cancer Center|April 20, 2002
The expanding role of epirubicin in the treatment of breast cancerStefan Glück
Case Reports in Oncology|January 24, 2013
Long-Term Complete Remission with nab-Paclitaxel, Bevacizumab, and Gemcitabine Combination Therapy in a Patient with Triple-Negative Metastatic Breast CancerAlberto Montero, Stefan Glück
Breast Cancer Research and Treatment|January 30, 2013
Molecularly targeted therapies for metastatic triple-negative breast cancerSoley Bayraktar, Stefan Glück
Oncology (Williston Park, N.Y.)|February 3, 2011
Improving outcomes in early-stage breast cancerStefan Glück, Terry Mamounas
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Clinical Breast Cancer|December 21, 2013
Extending the clinical benefit of endocrine therapy for women with hormone receptor-positive metastatic breast cancer: differentiating mechanisms of actionStefan Glück
The Oncologist|November 30, 2005
Adjuvant chemotherapy for early breast cancer: optimal use of epirubicinStefan Glück
Cancer Investigation|March 17, 2007
The prevention and management of distant metastases in women with breast cancerStefan Glück
American Journal of Clinical Oncology|September 5, 2009
Exemestane as first-line therapy in postmenopausal women with recurrent or metastatic breast cancerStefan Glück
Clinical Breast Cancer|October 1, 2016
Consequences of the Convergence of Multiple Alternate Pathways on the Estrogen Receptor in the Treatment of Metastatic Breast CancerStefan Glück
Clinical Breast Cancer|May 9, 2014
nab-Paclitaxel for the treatment of aggressive metastatic breast cancerStefan Glück
Cancer Control : Journal of the Moffitt Cancer Center|April 20, 2002
The expanding role of epirubicin in the treatment of breast cancerStefan Glück
Case Reports in Oncology|January 24, 2013
Long-Term Complete Remission with nab-Paclitaxel, Bevacizumab, and Gemcitabine Combination Therapy in a Patient with Triple-Negative Metastatic Breast CancerAlberto Montero, Stefan Glück
Breast Cancer Research and Treatment|January 30, 2013
Molecularly targeted therapies for metastatic triple-negative breast cancerSoley Bayraktar, Stefan Glück
Oncology (Williston Park, N.Y.)|February 3, 2011
Improving outcomes in early-stage breast cancerStefan Glück, Terry Mamounas
Pageof 8